TELA BIO, INC.— Sankey Diagram
Annual mode · period ending 2025-12-31 · SEC EDGAR
FY2025 - Q4(Oct 25 · Nov 25 · Dec 25)
Total Assets
$81M
↓-6.0% -$5Mvs FY2024
Total Liabilities
$75M
↑+29.2% +$17Mvs FY2024
Equity
$6M
↓-77.8% -$22Mvs FY2024
Cash
$51M
↓-3.5% -$2Mvs FY2024
Click a Metric or Sankey Node to View Historical Trends
Show Source Data (Audit Panel)
| Line item | FY2025 | FY2024 |
|---|---|---|
| Total Assets | $81M | $87M |
| Current Assets | $76M | $78M |
| Cash | $51M | $53M |
| ST Investments | $0 | $0 |
| Receivables | $0 | $0 |
| Inventory | $11M | $13M |
| Other Current | $14M | $13M |
| Non-Current Assets | $6M | $8M |
| PPE | $2M | $2M |
| Goodwill | $0 | $0 |
| Intangibles | $1M | $2M |
| Investments | $0 | $0 |
| Other Non-Current | $2M | $4M |
| Total Liab+Eq | $81M | $87M |
| Current Liab. | $18M | $16M |
| Accounts Payable | $2M | $2M |
| Short-Term Debt | $0 | $0 |
| Deferred Revenue | $0 | $0 |
| Other CL | $16M | $13M |
| Non-Current Liab. | $57M | $43M |
| Long-Term Debt | $56M | $41M |
| Other LT Liab. | $1M | $1M |
| Equity | $6M | $28M |
| Retained Earnings | $398M | $359M |
| Other Equity | $0 | $0 |
QuarterCharts · SEC EDGAR data · TELA · Comparing FY2025 vs FY2024